Loading...
The Cigna Group reported solid Q4 2025 performance, driven by growth in Evernorth Health Services and improved profitability, partially offset by impacts from the HCSC transaction.
Total revenue increased year over year driven by Evernorth growth.
Adjusted income from operations rose significantly versus prior year.
SG&A expense ratios improved reflecting business mix shift.
Medical Care Ratio remained stable year over year.
Cigna issued a constructive outlook for 2026, supported by Evernorth growth and disciplined cost management.
Analyze how earnings announcements historically affect stock price performance